Cargando…

Insulin‐like growth factor binding Protein‐4: A novel indicator of pulmonary arterial hypertension severity and survival

Proteomic analysis of patients with pulmonary arterial hypertension (PAH) has demonstrated significant abnormalities in the insulin‐like growth factor axis (IGF). This study proposed to establish associations between a specific binding protein, insulin‐like growth factor binding protein 4 (IGFBP4),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torres, Guillermo, Yang, Jun, Griffiths, Megan, Brandal, Stephanie, Damico, Rachel, Vaidya, Dhananjay, Simpson, Catherine E., Pauciulo, Michael W., Nichols, William C., Ivy, David D., Austin, Eric D., Hassoun, Paul M., Everett, Allen D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156920/ https://www.ncbi.nlm.nih.gov/pubmed/37152104 http://dx.doi.org/10.1002/pul2.12235

Ejemplares similares

Low‐affinity insulin‐like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survival
por: Torres, Guillermo, et al.
Publicado: (2023)

Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival
por: Yang, Jun, et al.
Publicado: (2020)

Pediatric Pulmonary Hypertension: Insulin Like Growth Factor Binding Protein 2 is a novel marker associated with disease severity and survival
por: Griffiths, Megan, et al.
Publicado: (2020)

Proteomics discovery of pulmonary hypertension biomarkers: Insulin‐like growth factor binding proteins are associated with disease severity
por: Nies, Melanie K., et al.
Publicado: (2022)

The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension
por: Simpson, Catherine E., et al.
Publicado: (2021)

COL18A1 genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association study
por: Simpson, Catherine E., et al.
Publicado: (2022)

Hepatoma‐derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival
por: Yang, Jun, et al.
Publicado: (2022)

Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease–Associated Pulmonary Hypertension
por: Daly, Caroline M., et al.
Publicado: (2021)

Chronic Allergic Inflammation Causes Vascular Remodeling and Pulmonary Hypertension in Bmpr2 Hypomorph and Wild-Type Mice
por: Mushaben, Elizabeth M., et al.
Publicado: (2012)

Therapeutic Hypothermia Modulates the Relationships Between Indicators of Severity of Neonatal Hypoxic Ischemic Encephalopathy and Serum Biomarkers
por: Chavez-Valdez, Raul, et al.
Publicado: (2021)

Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease
por: Zhu, Na, et al.
Publicado: (2018)

Perinatal Blood Biomarkers for the Identification of Brain Injury in Very Low Birth Weight Growth Restricted Infants
por: YUE, Shanna L., et al.
Publicado: (2021)

Promises and Pitfalls of Multiomics Approaches to Pulmonary Arterial Hypertension
por: Simpson, Catherine E., et al.
Publicado: (2022)

Racial and ethnic differences in pulmonary arterial hypertension
por: Al-Naamani, Nadine, et al.
Publicado: (2017)

Ventricular mass discriminates pulmonary arterial hypertension as redefined at the Sixth World Symposium on Pulmonary Hypertension
por: Simpson, Catherine E., et al.
Publicado: (2022)

Blood Biomarkers for Neonatal Hypoxic-Ischemic Encephalopathy in the Presence and Absence of Sentinel Events
por: BRONI, Eric K., et al.
Publicado: (2020)

Endostatin and ST2 are predictors of pulmonary hypertension disease course in infants.
por: Griffiths, Megan, et al.
Publicado: (2020)

United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications
por: Elliott, C. Gregory, et al.
Publicado: (2019)

Myocardial Fibrosis as a Potential Maladaptive Feature of Right Ventricle Remodeling in Pulmonary Hypertension
por: Simpson, Catherine E., et al.
Publicado: (2019)

Deriving Convergent and Divergent Metabolomic Correlates of Pulmonary Arterial Hypertension
por: Alotaibi, Mona, et al.
Publicado: (2023)

Serum uric acid as a marker of disease risk, severity, and survival in systemic sclerosis-related pulmonary arterial hypertension
por: Simpson, Catherine E., et al.
Publicado: (2019)

Hepatoma derived growth factor binds DNA through the N-terminal PWWP domain
por: Yang, Jun, et al.
Publicado: (2007)

Spatial and temporal resolution of metabolic dysregulation in the Sugen hypoxia model of pulmonary hypertension
por: Simpson, Catherine E., et al.
Publicado: (2023)

A novel approach to perioperative risk assessment for patients with pulmonary hypertension
por: Hassan, Hussein J., et al.
Publicado: (2021)

Serum brain injury biomarkers are gestationally and post-natally regulated in non-brain injured neonates
por: Brooks, Sandra, et al.
Publicado: (2023)

Human liver single nuclear RNA sequencing implicates BMPR2, GDF15, arginine, and estrogen in portopulmonary hypertension
por: Jose, Arun, et al.
Publicado: (2023)

Echocardiography in Pediatric Pulmonary Hypertension
por: Jone, Pei-Ni, et al.
Publicado: (2014)

Pulmonary Hypertension in the Population with Down Syndrome
por: Bush, Douglas S., et al.
Publicado: (2022)

Impact of 3-year changes in fasting insulin and insulin resistance indices on incident hypertension: Tehran lipid and glucose study
por: Baghbani-Oskouei, Aidin, et al.
Publicado: (2019)

RASA3 is a candidate gene in sickle cell disease‐associated pulmonary hypertension and pulmonary arterial hypertension
por: Prohaska, Clare C., et al.
Publicado: (2023)

Circulating Cytokines and Growth Factors in Pediatric Pulmonary Hypertension
por: Duncan, Mark, et al.
Publicado: (2012)

Multi‐Beat Right Ventricular‐Arterial Coupling Predicts Clinical Worsening in Pulmonary Arterial Hypertension
por: Hsu, Steven, et al.
Publicado: (2020)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseases
por: Boueiz, Adel, et al.
Publicado: (2014)

Estradiol Binds to Insulin and Insulin Receptor Decreasing Insulin Binding in vitro
por: Root-Bernstein, Robert, et al.
Publicado: (2014)

Fibronectin as a Prognostic Indicator in Portal Hypertension
por: Mckee, Ruth F., et al.
Publicado: (1992)

Shri Madhavacharya Gurukulam, Pune: An attempt to strengthen roots of classical Ayurveda
por: Kulkarni, Vaidya Dhananjay
Publicado: (2012)

Risk Stratification of Patients with Pulmonary Arterial Hypertension: The Role of Echocardiography
por: Mercurio, Valentina, et al.
Publicado: (2022)

Causes and outcomes of ICU hospitalisations in patients with pulmonary arterial hypertension
por: Naranjo, Mario, et al.
Publicado: (2022)

Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children
por: Frank, Benjamin S., et al.
Publicado: (2018)

Systemic Sclerosis-Associated Pulmonary Hypertension: Spectrum and Impact
por: Naranjo, Mario, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i8jei28p5kf8j6jjr5shqp9sb2